Nevertheless, in our study, we found that the expression of p-mTOR and p-S6 was decreased at 4th week, while gradually increased at 6-8 weeks (Figure S12A-B), indicating that the activity of mTOR was inhibited firstly and then elevated along with the process of cisplatin-induced CKD. This evidence concerns the gene MTOR and chronic kidney disease.